טוען...
Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson’s disease
BACKGROUND: Inhaled levodopa may quickly resolve off periods in Parkinson’s disease. Our aim was to determine the pharmacokinetics and tolerability of a new levodopa dry-powder inhaler. METHODS: A single-centre, single-ascending, single-dose–response study was performed. Over three visits, eight Par...
שמור ב:
| הוצא לאור ב: | Ther Adv Chronic Dis |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6589987/ https://ncbi.nlm.nih.gov/pubmed/31258882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622319857617 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|